Teva To Get EU OK For Cephalon Takeover -Reuters
October 10 2011 - 11:27AM
Dow Jones News
Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive
conditional clearance from the European Union for its almost $7
billion takeover of U.S. specialty drugmaker Cephalon Inc. (CEPH),
Reuters reported Monday citing a person with direct knowledge of
the matter.
The EU executive, which is scheduled to decide by Oct. 13
whether to clear the acquisition, wasn't immediately available for
comment, Reuters said.
Full story at
http://www.reuters.com/article/2011/10/10/us-cephalon-teva-eu-idUSTRE7993OH20111010
-Dow Jones Newswires; 212-416-2900
Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Apr 2024 to May 2024
Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Cephalon (MM) (NASDAQ): 0 recent articles
More Cephalon Inc. News Articles